CERESITY
LIVE

Serial Number

50095252

Owner

Ceresity Technologies, Inc.

Attorney

ALIAKSANDR LAZOUSKI

Filing Date

Sep 8, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CERESITY Trademark

Serial Number: 50095252

CERESITY is a trademark filed by Ceresity Technologies, Inc. on September 8, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Ceresity Technologies, Inc.

791, Alexander Road
Princeton, NJ 08540

Entity Type: 03

Trademark Details

Filing Date

September 8, 2026

Registration Date

Not Registered

Goods & Services

Downloadable computer software for analyzing clinical trial protocols, identifying clinical trial design and operational risks, generating recommendations, and comparing alternative clinical trial designs in the field of clinical research; Downloadable computer simulation software for modeling modeling clinical trial designs and projected clinical trial outcomes; Downloadable computer software using machine learning for developing predictive models; Downloadable computer software for aggregating clinical trial data from disparate source systems and establishing data lineage and traceability to Clinical Data Interchange Standards Consortium (CDISC) data standards, namely, Study Data Tabulation Model (SDTM), Analysis Data Model (ADaM), and Clinical Data Acquisition Standards Harmonization (CDASH); Downloadable software for generating clinical data governance and metadata lineage reports

Software as a service (SAAS) services, namely, hosting software for use by others for analyzing clinical trial protocols, identifying clinical trial design and operational risks, generating recommendations, and comparing alternative clinical trial designs in the field of clinical research; Providing online non-downloadable computer software platforms for analyzing clinical trial protocols, identifying clinical trial design and operational risks, generating evidence-backed recommendations, and comparing alternative clinical trial designs; Providing online non-downloadable software using machine learning for analyzing clinical trial protocol data, identifying clinical trial design and operational risks, and generating predictive metrics in the field of clinical research; Providing temporary use of online non-downloadable simulation software for modeling clinical trial designs and projected clinical trial outcomes; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for creating complex data science analyses; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of on-line non-downloadable software for aggregating and mapping clinical trial data from electronic data capture, laboratory, imaging, and other clinical source systems to Clinical Data Interchange Standards Consortium (CDISC) data standards; Software as a service (SAAS) services featuring software for managing clinical metadata governance, tracking data lineage, and performing automated quality control of clinical datasets; Providing on-line non-downloadable software for generating clinical data governance reports for use in regulatory submissions

Business data analysis services in the field of clinical trials; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Statistical analysis and reporting services for business purposes; Analyzing and compiling business data for clinical trial protocol optimization, operational risk assessment, clinical trial metadata governance, and data governance reporting purposes; Business consulting and management in the field of clinical trials, namely, providing information management services

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 8, 2026 MAFR
NEW APPLICATION ENTERED
Sep 8, 2026 NWAP